Manufacturers Life Insurance Company, The Celldex Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 104,376 shares of CLDX stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,376

Previous 105,777 1.32%

Holding current value

$2.13 Million

Previous $3.59 Million 26.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $32,657 - $45,392	-1,401 Reduced 1.32%	104,376 $2.64 Million
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $769,760 - $1.07 Million	-24,010 Reduced 18.5%	105,777 $3.59 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $7,960 - $10,342	243 Added 0.19%	129,787 $4.8 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $3.03 Million - $4.47 Million	86,117 Added 198.3%	129,544 $5.44 Million
Q4 2023 Feb 13, 2024	SELL	$22.61 - $40.65 $144,817 - $260,363	-6,405 Reduced 12.85%	43,427 $1.72 Million
Q3 2023 Nov 15, 2023	BUY	$25.45 - $37.46 $118,749 - $174,788	4,666 Added 10.33%	49,832 $1.37 Million
Q2 2023 Aug 11, 2023	SELL	$30.29 - $38.28 $408,460 - $516,205	-13,485 Reduced 22.99%	45,166 $1.53 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $84,411 - $115,112	2,427 Added 4.14%	61,078 $2.2 Million
Q4 2022 Aug 11, 2023	BUY	$27.78 - $45.38 $116,314 - $190,006	4,187 Added 7.69%	58,651 $2.61 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $116,314 - $190,006	4,187 Added 7.69%	58,651 $2.61 Million
Q3 2022 Aug 11, 2023	BUY	$22.7 - $37.57 $98,313 - $162,715	4,331 Added 8.64%	54,464 $1.53 Million
Q3 2022 Nov 03, 2022	BUY	$22.7 - $37.57 $98,313 - $162,715	4,331 Added 8.64%	54,464 $1.54 Million
Q2 2022 Aug 11, 2023	SELL	$20.5 - $37.33 $274,249 - $499,400	-13,378 Reduced 21.06%	50,133 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $274,249 - $499,400	-13,378 Reduced 21.06%	50,133 $1.38 Million
Q1 2022 Aug 11, 2023	BUY	$27.64 - $39.32 $67,248 - $95,665	2,433 Added 3.98%	63,511 $2.16 Million
Q1 2022 May 20, 2022	BUY	$27.64 - $39.32 $1.11 Million - $1.58 Million	40,225 Added 172.74%	63,511 $2.19 Million
Q4 2021 Feb 16, 2022	SELL	$35.68 - $56.27 $3,318 - $5,233	-93 Reduced 0.4%	23,286 $903,000
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $36,013 - $69,651	1,244 Added 5.62%	23,379 $1.26 Million
Q2 2021 Aug 12, 2021	BUY	$20.71 - $35.37 $458,415 - $782,914	22,135 New	22,135 $740,000

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $955M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Celldex Therapeutics, Inc. Transaction History